251 related articles for article (PubMed ID: 33421619)
1. Targeting epigenetic regulatory machinery to overcome cancer therapy resistance.
Guo L; Lee YT; Zhou Y; Huang Y
Semin Cancer Biol; 2022 Aug; 83():487-502. PubMed ID: 33421619
[TBL] [Abstract][Full Text] [Related]
2. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
3. Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
Perez-Plasencia C; Duenas-Gonzalez A
Mol Cancer; 2006 Jul; 5():27. PubMed ID: 16831224
[TBL] [Abstract][Full Text] [Related]
4. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors.
Kumar A; Emdad L; Fisher PB; Das SK
Adv Cancer Res; 2023; 158():73-161. PubMed ID: 36990539
[TBL] [Abstract][Full Text] [Related]
5. Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
Raynal NJ; Da Costa EM; Lee JT; Gharibyan V; Ahmed S; Zhang H; Sato T; Malouf GG; Issa JJ
Mol Cancer Ther; 2017 Feb; 16(2):397-407. PubMed ID: 27980103
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistance.
Ponnusamy L; Mahalingaiah PKS; Singh KP
Adv Clin Chem; 2020; 94():219-259. PubMed ID: 31952572
[TBL] [Abstract][Full Text] [Related]
7. Epigenomics and breast cancer.
Lo PK; Sukumar S
Pharmacogenomics; 2008 Dec; 9(12):1879-902. PubMed ID: 19072646
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics and oncology.
Mummaneni P; Shord SS
Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
10. Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators.
Rauscher S; Greil R; Geisberger R
Curr Cancer Drug Targets; 2021; 21(4):353-359. PubMed ID: 33423645
[TBL] [Abstract][Full Text] [Related]
11. Targeting the cancer epigenome for therapy.
Jones PA; Issa JP; Baylin S
Nat Rev Genet; 2016 Sep; 17(10):630-41. PubMed ID: 27629931
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic targeting therapies to overcome chemotherapy resistance.
Balch C; Nephew KP
Adv Exp Med Biol; 2013; 754():285-311. PubMed ID: 22956507
[TBL] [Abstract][Full Text] [Related]
13. Using Epigenetic Therapy to Overcome Chemotherapy Resistance.
Strauss J; Figg WD
Anticancer Res; 2016 Jan; 36(1):1-4. PubMed ID: 26722021
[TBL] [Abstract][Full Text] [Related]
14. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic enzyme mutations as mediators of anti-cancer drug resistance.
Chen S; Zhao Y; Liu S; Zhang J; Assaraf YG; Cui W; Wang L
Drug Resist Updat; 2022 Mar; 61():100821. PubMed ID: 35219075
[TBL] [Abstract][Full Text] [Related]
16. Epidrugs: targeting epigenetic marks in cancer treatment.
Miranda Furtado CL; Dos Santos Luciano MC; Silva Santos RD; Furtado GP; Moraes MO; Pessoa C
Epigenetics; 2019 Dec; 14(12):1164-1176. PubMed ID: 31282279
[TBL] [Abstract][Full Text] [Related]
17. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets for epigenetic therapy of cancer.
Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
Curr Pharm Biotechnol; 2009 Feb; 10(2):161-5. PubMed ID: 19199948
[TBL] [Abstract][Full Text] [Related]
19. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
[TBL] [Abstract][Full Text] [Related]
20. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements.
Singh D; Khan MA; Siddique HR
Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]